Home > Review Articles > Medical workforce > Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland

Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland

Making Education Easy

Authors:
Summary:

The Getting Better at Chronic Care Project (GBACC) was designed to improve the care of Indigenous adults with poorly controlled type 2 diabetes (HbA1c ≥69 mmol/mol) and ≥1 comorbidity living in 12 rural and remote north Queensland communities. Eighty-seven such people in 6 intervention communities received, in addition to standard primary care, intensive chronic condition management for 18 months, delivered by Indigenous health workers (IHWs) who had a Certificate III or IV in Aboriginal and/or Torres Strait Islander Primary Health Care. The IHWs received additional training in diabetes management and intensive support from the clinical support team. The Indigenous health worker-supported (IHW-S) model was family-centred and based on community outreach. A total of 106 patients in 6 usual care (UC) communities received input from a centre-based primary care team (nurses, general practitioners, IHWs, etc.), with less intensive IHW support. This paper reports the outcomes of a cost–consequence analysis for implementation of this intensive management, covering the period from 1 March 2012 to 5 September 2013. The mean cost of the 18-month intervention trial was $AU10,060 per person ($AU6,706/year). The intervention was associated with a nonsignificantly greater reduction in mean HbA1c levels (–10.1 mmol/mol in the IHW-S group vs –5.4 mmol/mol in the UC group; p=0.17), a significant reduction in the proportion with extremely poor diabetes control (HbA1c ≥102 mmol/mol; p=0.002), and a sub-significant differential reduction in hospitalisation rates for type 2 diabetes as primary diagnosis (–0.09 admissions/person/year; p=0.06), with a net reduction in mean annual hospital costs of $646/person (p=0.07). Quality of life utility scores declined in both groups (between-group difference, p=0.62) and both had high rates of disease progression (between-group difference, p=0.73).

Comment:
See below.
Reference: Med J Aust. 2016;204(5):196
Independent commentary by Dr. Matire Hardwood

Dr Matire Harwood (Ngapuhi) has worked in Hauora Māori, primary health and rehabilitation settings as clinician and researcher since graduating from Auckland Medical School in 1994. She also holds positions on a number of boards, committees and advisory groups including the Health Research Council. Matire lives in Auckland with her whānau including partner Haunui and two young children Te Rangiura and Waimarie.

Research Review publications are intended for New Zealand health professionals.

Disclaimer: This publication is not intended as a replacement for regular medical education but to assist in the process. The reviews are a summarised interpretation of the published study and reflect the opinion of the writer rather than those of the research group or scientific journal. It is suggested readers review the full trial data before forming a final conclusion on its merits.

Related Articles

Differences in glycosylated haemoglobin (HbA1c) according to ethnic group are apparent in New Zealand children

A review of a regional diabetes service in Auckland has highlighted an increasing incidence of

Explicit ethnicity-based eligibility criteria may help overcome access to care barriers for patients with diabetes,

Explore Māori Health Reviews

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

It looks like you are closest to our Australia site.

Australia
Australia
Find Reviews in Your Clinical Area
Please select your country of practice.
Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.